Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Transl Res. 2015 Jan 13;166(1):57–69. doi: 10.1016/j.trsl.2015.01.001

Figure 5. Total and differential cell counts in BALF following repetitive DE exposures in mice receiving pretreatment with MaR1.

Figure 5

Mice were pretreated with 0 or 10 ng MaR1 given i.p. 30 minutes prior to an intranasal dose of DE, given daily for 15 consecutive weekdays. At five hours following the final MaR1/DE exposure, BALF were retrieved. Total cell counts were enumerated (A), as well as differential counts of neutrophils and macrophages (B) and lymphocytes (C). ### p < 0.001 compared to vehicle + saline group; ## p < 0.01 compared to vehicle + saline group; # p < 0.05 compared to vehicle + saline group; *** p < 0.001 versus DE treatment group. Data are represented as mean values with standard error bars. N ≥ 5 mice for control groups and N≥ 10 mice for treatment groups.